Vaccines for the Future provides quarterly updates on our efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against pneumonia (pneumococcal disease) and diarrheal disease (rotavirus, Shigella, enterotoxigenic Escherichia coli), as well as new vaccines for the global population against influenza, meningitis, polio, and respiratory syncytial virus. It includes updates on our progress, partnerships, and specific activities related to these projects.

PATH and the US Department of Health and Human Services (HHS) work together to protect and improve health in developing countries. This fact sheet provides examples of successes that PATH, HHS, and our partners have had in developing and deploying new global health technologies to prevent, detect, and control epidemic and neglected diseases, advance health research, and save lives around the world.

In Kenya, malaria in pregnancy continues to contribute to high maternal and newborn morbidity and mortality. By translating emerging evidence on community-based distribution of antimalarial medicine into policy action, policymakers in Kenya have the opportunity to significantly decrease malaria-related mortality and morbidity during pregnancy, safeguarding the health and lives of countless women and newborns. This brief describes recommendations and policies at the global level and in Kenya and identifies ways in which to expand access to preventive treatment for mothers.

This brochure outlines PATH's work in China, with emphasis on public-private partnerships for product development. Areas of focus include vaccines and immunization, health technologies, and women's health.

This project brief describes PATH's work in the Democratic Republic of Congo to control and treat multidrug-resistant tuberculosis (MDR-TB). The brief outlines a project to train national clinicians to diagnose MDR-TB, strengthen the diagnostic capacities of local laboratories, and mobilize communities to help patients successfully complete treatment. All of this work was made possible with generous funding from the United States Agency for International Development.

This fact sheet describes the Healthy Markets project, which is designed to grow the commercial market for HIV-related goods and services to meet the needs of Vietnam's most-at-risk populations. The project offers market and consumer behavior research, policy and regulatory support, technical assistance, and private-sector engagement opportunities to encourage innovation and investment.

This project brief explains how PATH worked to improve tuberculosis (TB) data collection methods at the local level in the Democratic Republic of Congo, which led to more timely and accurate reporting of data to national and global stakeholders, allowing officials to have more relevant discussions around TB control. All of this work was made possible with generous funding from the United States Agency for International Development.

This project brief outlines PATH's work to improve integrated services for tuberculosis (TB) and HIV in various districts throughout Vietnam using a public-private mix model. The brief details how the project was piloted and adapted over time to successfully improve TB and HIV case detection and treatment in the project sites. All of this work was made possible with generous funding from the United States Agency for International Development.

This fact sheet provides an overview of PATH's support to the government of Vietnam on tuberculosis control activities, including the public-private mix referral mechanism and advocacy, communications, and social mobilization strategy.

This project brief explains the activities and outcomes of PATH's work in the Democratic Republic of Congo to control and treat tuberculosis (TB) and HIV co-infection. By introducing and scaling up a comprehensive package of collaborative interventions, PATH influenced TB-HIV planning at the national level, activities in the field, and community access to integrated TB-HIV services. All of this work was made possible with generous funding from the United States Agency for International Development.

This project brief outlines PATH's work in training employees of national tuberculosis (TB) programs and civil-society organizations to conduct advocacy, communication, and social mobilization (ACSM) activities aimed at improving TB case detection and treatment outcomes in their countries. This work was made possible with funding from the United States Agency for International Development.

This project brief outlines PATH's role in supporting the creation of the Africa Coalition on Tuberculosis (ACT!), a core group of committed activists from high-burden tuberculosis countries in sub-Saharan Africa. This work was made possible with generous funding from the United States Agency for International Development.

Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. This fact sheet describes the cross-sector partnership PATH formed to develop a new way to produce high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply.

This success story displays positive outcomes of PATH's work in the Democratic Republic of Congo related to the control and treatment of tuberculosis, achieved through leveraging the strength of the community. This work was made possible with generous funding from the United States Agency for International Development.